Labiotech.eu (blog)New Stem Cells Could Take Cell Research and Therapies to the Next LevelLabiotech.eu (blog)British researchers have created a new type of stem cell in mice. It has even greater potential than current cell lines in research and in the … Continue reading
Seeking AlphaNightstar Therapeutics – Novel Gene Therapy Company And Recent IPOSeeking AlphaLondon, UK and Lexington, Massachusetts based gene therapy company Nightstar Therapeutics (NITE) recently launched its IPO on NASDAQ offering 5.36 million ADS (… Continue reading
KL DailyBrainStorm enrolls first patients in advanced ALS stem cell trialBusiness InsiderTEL AVIV, Oct 16 (Reuters) – BrainStorm Cell Therapeutics said the first patients have been enrolled in a late-stage trial of its treatment for amyotrophic lateral… Continue reading
WeeklyHubBrainStorm enrolls first patients in advanced ALS stem cell trialReutersTEL AVIV (Reuters) – BrainStorm Cell Therapeutics said the first patients have been enrolled in a late-stage trial of its treatment for amyotrophic lateral sclerosis (ALS)… Continue reading
KL DailyBrainStorm enrolls first patients in advanced ALS stem cell trialReutersTEL AVIV (Reuters) – BrainStorm Cell Therapeutics said the first patients have been enrolled in a late-stage trial of its treatment for amyotrophic lateral sclerosis (ALS) … Continue reading
KL DailyBrainStorm enrolls first patients in advanced ALS stem cell trialWHTCTEL AVIV (Reuters) – BrainStorm Cell Therapeutics said the first patients have been enrolled in a late-stage trial of its treatment for amyotrophic lateral sclerosis (ALS) at … Continue reading
KL DailyBrainStorm enrolls first patients in advanced ALS stem cell trialNasdaqTEL AVIV, Oct 16 (Reuters) – BrainStorm Cell Therapeutics said the first patients have been enrolled in a late-stage trial of its treatment for amyotrophic lateral sclerosis… Continue reading
Cosmos (blog) |
Gene therapy for blindness heading for approval
Cosmos (blog) The US Food and Drug Administration looks set to approve a gene therapy for the treatment of a rare form of blindness, following clinical trials and the recommendation of a panel of independent advisors. The therapy, marketed as Luxturna by developers … Spark Therapeutics’s success is lifting all gene therapy stocks even though risks remainSTAT (blog) New gene therapy gives hope to people born with inherited eye disorderThe Conversation UK FDA advisory committee vote 16-0 for first even gene therapy for rare blindnessNews-Medical.net PBS NewsHour –Science Recorder all 8 news articles » |